Home Network Structure Members Area Contact Us Help  












Newsletter
 
Public databases with primary data are ...
  useful
  a lot of work
  too much work
  not reliable due to lack of validation
Description of Work
MUGEN aims to structure and shape a world-class network of European scientific and technological excellence in the field of 'murine models of human immunological disease', to advance understanding of the genetic basis of disease and to enhance innovation and translatability of research efforts.

MUGEN's specific mission is to bring together different expertise from academic and industrial laboratories in order to study human immunological disease by integrating the participant's strengths in immunological knowledge with new approaches in functional genomics. In this way MUGEN expects to bring Europe a competitive advantage in the development of new diagnostic and therapeutic tools. In concert, MUGEN promotes training of young researchers and exploitation, dissemination and communication of scientific and technological excellence both within and outside of the network, to include all interested stakeholders in the area of human immunological diseases.

Moving towards the 4th JPA, MUGEN is focusing on further supporting already established capabilities, through greater integration of already set up services as well as investment on the development of new technological cores, expanding and enriching its research efforts and diversifying its dissemination initiatives to raise awareness.
Work packages
21. Phenotyping Core Lead Participant - Helmholtz-Hzi
Leading Scientist - Dr. W. Mueller and Dr. M. Hafner
22. Genotyping Core Lead Participant - Fleming
Leading Scientist - Dr George Kollias
23. Awareness and Dissemination Lead Participant - Fleming
Leading Scientist - Dr. George Kollias
24. Preclinical Drug Evaluation Platform Analysis Lead Participant - Biomedcode
Leading Scientist - Biomedcode
3 Pages: 1, 2, 3
Copyright 2013 © Biomedical Sciences Research Centre "Al. Fleming" | Disclaimer | Privacy Policy